series-c-plus
Stage
2014
Founded
3
Investors
About
IO Biotech is a clinical-stage biopharmaceutical company developing off-the-shelf therapeutic cancer vaccines designed to modulate the tumor microenvironment and enhance anti-tumor immune responses.
Explore IO Biotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.